Adam J. Wolpaw, MD, PhD Adam J. Wolpaw, MD, PhD, is an attending physician with the Division of Oncology at Children's Hospital of Philadelphia. Locations: Main Campus Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467) Education and Training Medical SchoolMD - Columbia College of Physicians and Surgeons, New York, NY ResidencyPediatrics - The Children’s Hospital of Philadelphia, Philadelphia, PA FellowshipHematology-Oncology - The Children’s Hospital of Philadelphia, Philadelphia, PA Board CertificationPediatricsGraduate DegreePhD in Chemical Biology - Columbia University, New York, NY Master of Philosophy in Pharmacology - Cambridge University, England Titles and Academic Titles Attending PhysicianInstructor in Pediatrics, Division of Oncology, Perelman School of Medicine at the University of Pennsylvania Departments and Services Cancer Center Publications Papers2018 Wolpaw AJ, Dang CV. “MYC-induced Metabolic Stress and Tumorigenesis.” Biochim Biophys Acta. (2018) 1870(1):43-50. 2017 Wolpaw AJ, Dang CV. “Exploiting Metabolic Vulnerabilities of Cancer with Precision and Accuracy.” Trends Cell Biol. (2017) 28(3):201-212. 2016 Shimada K, Skouta R, Kaplan A, Yang WS, Hayano M, Dixon SJ, Brown LM, Valenzuela CA, Wolpaw AJ, Stockwell BR. “Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis.” Nat Chem Biol (2016) 12, 497-503. 2015 Wolpaw AJ, Trella JD, Egan MA, Delgado EM. “New-Onset Hypoglycemia in a Medically Complex 6-Year-Old Girl.” Pediatr Emerg Care (2015) 31:883-886. 2014 Wolpaw AJ, Stockwell BR. "Multidimensional profiling in the investigation of small-molecule-induced cell death." Methods in Enzymology (2014) 545:265-302. 2013 Varma H, Gangadhar NM, Letso RR, Wolpaw AJ, Sriramaratnam R, and Stockwell BR “Identification of a small molecule that induces ATG5-and-cathepsin-l-dependent cell death and modulates polyglutamine toxicity.” Exp Cell Res (2013) 319, 1759-1773. 2011 Wolpaw AJ, Shimada K, Skouta R, Welsch ME, Akavia UR, Pe’er D, Shaik F, Bulinski JC, Stockwell BR. “Modulatory profiling identifies mechanisms of small molecule-induced cell death.” Proc Natl Acad Sci U S A 108, E771-780 (2011) 2007 Yagoda N, von Rechenberg M, Zaganjor E, Bauer AJ, Yang WS, Fridman DJ, Wolpaw AJ, Smukste I, Peltier JM, Boniface JJ, Smith R, Lessnick SL, Sahasrabudhe S, Stockwell BR. “RAS-RAF-MEK-dependent oxidative cell death involving voltage-dependent anion channels.” Nature 447 (2007) 864-868 Lim JC, Wolpaw AJ, Caldwell MA, Hladky SB, Barrand MA. “Neural precursor cell influences on blood-brain barrier characteristics in rat brain endothelial cells.” Brain Research 1159 (2007) 67-76. 2003 Wolpaw AJ, Aizer AA, Zimmt MB. “Synthesis of self-orienting triptycene adsorbates for STM investigations.” Tetrahedron Letters 44 (2003) 7613-7615 Posters and Presentations2018 Wolpaw AJ, Volgina, D, Dang CV. “Modulation of Innate Immune Sensing Pathways in Neuroblastoma by MYCN.” Advances in Neuroblastoma Research, May 2018. Invited Lectures 2018 Wolpaw AJ. “Modulation of innate immune sensing pathways by N-MYC.” Children’s Oncology Group Fall Meeting. October 2018. Awards and Honors 2012, Titus Munson Coan Prize for Best Essay in the Biological Sciences 2011, PhD with honors, Columbia University 2008, Student Travel Award, Gordon Conference on Cell Death 2007, Solomon Snyder Scholar, Academy of Achievement Summit 2003, Honors in Chemistry, Brown University 2003, Magna Cum Laude, Brown University 2003, Churchill Fellowship 2002, Junior Award in Chemistry, Brown University 2002, Barry Goldwater Scholarship for Excellence in Education Patient Experience Ratings About the Patient Experience Rating System The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question. Responses are measured on a scale of 1 to 5 with 5 being the best score. We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments. Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care. The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.